Cubist Systematic Strategies
CTSO icon

Cubist Systematic Strategies’s Cytosorbents Corp CTSO Stock Holding History

Cubist Systematic Strategies’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-627
Closed -$27K – 4466
2022
Q2 		$27K Sell
627
-266
-30% -$12.2K ﹤0.01% 4182
2022
Q1 		$57K Buy
+893
New +$64K ﹤0.01% 3353
2021
Q3 		– Sell
-484
Closed -$73K – 2988
2021
Q2 		$73K Sell
484
-151
-24% -$25.4K ﹤0.01% 2752
2021
Q1 		$110K Sell
635
-1,246
-66% -$238K ﹤0.01% 2624
2020
Q4 		$300K Sell
1,881
-3,124
-62% -$523K ﹤0.01% 2036
2020
Q3 		$798K Buy
5,005
+1,808
+57% +$326K 0.01% 1467
2020
Q2 		$633K Buy
+3,197
New +$587K 0.01% 1461

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Cubist Systematic Strategies's CTSO Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 627 shares — an estimated $27K sold.

Cubist Systematic Strategies first reported a position in CTSO in Q2 2020 and held it in 7 quarters. The position peaked at $798K in Q3 2020. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 627 Cytosorbents Corp shares in Q3 2022, an estimated $27K.
  • Cubist Systematic Strategies first reported a position in Cytosorbents Corp in Q2 2020 and held it in 7 quarters.
  • Cubist Systematic Strategies's Cytosorbents Corp position peaked at $798K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.